Work

Preclinical enzyme replacement therapy with a recombinant β-galactosidase-lectin fusion for CNS delivery and treatment of GM1-gangliosidosis

Year: 2023
Type: article
Study design: Observational Study
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4319456134
FWCI:
Cites:
Cited by:
Related to: 10